American Century Companies’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
ACA
DCM
PCH
American Century Companies's XENE Position: Q1 2026 in Review
American Century Companies reduced its Xenon Pharmaceuticals (XENE) stake by 0.17% in Q1 2026, selling an estimated $53.4K and leaving 679,314 shares worth $39.5M. The position accounts for 0.02% of the portfolio, ranked #859.
American Century Companies first reported a position in XENE in Q3 2022 and has held it in 10 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.
- American Century Companies held 679,314 shares of Xenon Pharmaceuticals worth $39.5M as of Q1 2026.
- American Century Companies sold 1,159 Xenon Pharmaceuticals shares in Q1 2026, an estimated $53.4K.
- Xenon Pharmaceuticals made up 0.02% of American Century Companies's portfolio in Q1 2026, its #859 holding.
- American Century Companies first reported a position in Xenon Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
- 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.